- Home
- CLGN vs HFBL Comparison
CLGN vs HFBL Comparison
Compare CLGN & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- HFBL
- Stock Information
- Founded
- CLGN 2004
- HFBL 1924
- Country
- CLGN Israel
- HFBL United States
- Employees
- CLGN N/A
- HFBL N/A
- Industry
- CLGN Industrial Specialties
- HFBL Savings Institutions
- Sector
- CLGN Health Care
- HFBL Finance
- Exchange
- CLGN Nasdaq
- HFBL Nasdaq
- Market Cap
- CLGN 22.1M
- HFBL 41.7M
- IPO Year
- CLGN N/A
- HFBL N/A
- Fundamental
- Price
- CLGN $2.28
- HFBL $12.90
- Analyst Decision
- CLGN Strong Buy
- HFBL
- Analyst Count
- CLGN 2
- HFBL 0
- Target Price
- CLGN $11.50
- HFBL N/A
- AVG Volume (30 Days)
- CLGN 173.3K
- HFBL 1.9K
- Earning Date
- CLGN 05-28-2025
- HFBL 07-25-2025
- Dividend Yield
- CLGN N/A
- HFBL 4.03%
- EPS Growth
- CLGN N/A
- HFBL N/A
- EPS
- CLGN N/A
- HFBL 1.09
- Revenue
- CLGN $2,472,000.00
- HFBL $20,019,000.00
- Revenue This Year
- CLGN $2,177.67
- HFBL N/A
- Revenue Next Year
- CLGN $56.52
- HFBL N/A
- P/E Ratio
- CLGN N/A
- HFBL $11.80
- Revenue Growth
- CLGN N/A
- HFBL N/A
- 52 Week Low
- CLGN $1.55
- HFBL $10.84
- 52 Week High
- CLGN $5.60
- HFBL $14.25
- Technical
- Relative Strength Index (RSI)
- CLGN 49.21
- HFBL 46.36
- Support Level
- CLGN $1.90
- HFBL $12.90
- Resistance Level
- CLGN $4.98
- HFBL $13.84
- Average True Range (ATR)
- CLGN 0.45
- HFBL 0.19
- MACD
- CLGN 0.16
- HFBL -0.03
- Stochastic Oscillator
- CLGN 21.28
- HFBL 15.32
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.